tiprankstipranks
Amgen data ‘muddies’ outlook for Cartesian, says Oppenheimer
PremiumThe FlyAmgen data ‘muddies’ outlook for Cartesian, says Oppenheimer
12d ago
Amgen reports new data from Phase 3 registrational MINT trial of Uplinza
Premium
The Fly
Amgen reports new data from Phase 3 registrational MINT trial of Uplinza
12d ago
Amgen’s Mixed Trial Results and Competitive Challenges Lead to Hold Rating
Premium
Ratings
Amgen’s Mixed Trial Results and Competitive Challenges Lead to Hold Rating
12d ago
Cautious Hold Rating on Amgen Amid Rocatinlimab’s Efficacy and Safety Concerns
PremiumRatingsCautious Hold Rating on Amgen Amid Rocatinlimab’s Efficacy and Safety Concerns
15d ago
Amgen, Kyowa announces new results from ongoing ROCKET Phase 3 study
Premium
The Fly
Amgen, Kyowa announces new results from ongoing ROCKET Phase 3 study
16d ago
TKO, Nike, Amgen, Macy’s, Marathon: Trending by Analysts
Premium
Weekend Updates
TKO, Nike, Amgen, Macy’s, Marathon: Trending by Analysts
17d ago
S&P 500 (SPX) Dives as Trump’s Trade War Heats Up
PremiumMarket NewsS&P 500 (SPX) Dives as Trump’s Trade War Heats Up
21d ago
Amgen, AstraZeneca announce results from Phase 3 WAYPOINT trial on tezspire
Premium
The Fly
Amgen, AstraZeneca announce results from Phase 3 WAYPOINT trial on tezspire
23d ago
Amgen’s Strong Growth Potential and Strategic Positioning Justify Buy Rating
Premium
Ratings
Amgen’s Strong Growth Potential and Strategic Positioning Justify Buy Rating
27d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100